Regeneron Pharmaceuticals (REGN)
Gross Profit Growth
18.08%
Quarterly · Period ending:
REGN Gross Profit Growth
Year-over-year change vs the same period a year earlier
Latest reported18.08%period ending
Latest reported18.08%period ending
REGN Quarterly Gross Profit YoY % (66.67% → 18.08%)
Year-over-year change
High-resolution chart · PNG
REGN gross profit growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Gross Profit Growth |
|---|---|
| 18.0836% | |
| 14.4907% | |
| 2.3544% | |
| 0.096% | |
| 2.5596% | |
| -5.4146% | |
| 14.9223% | |
| 14.4883% | |
| 15.7277% | |
| 4.0728% | |
| -3.5152% | |
| 11.6834% | |
| 6.6138% | |
| 4.795% | |
| -25.3479% | |
| -13.6892% | |
| -43.1671% | |
| 15.4461% | |
| 93.9445% | |
| 49.2528% | |
| 170.3653% | |
| 38.4937% | |
| 26.4945% | |
| 33.8088% | |
| 17.2331% | |
| 35.2588% | |
| -10.2012% | |
| -3.4517% | |
| -6.9345% | |
| -15.4922% | |
| 22.5795% | |
| 11.6995% | |
| 11.3095% | |
| 13.6642% | |
| 28.3957% | |
| 18.3499% | |
| 16.4807% | |
| 9.8808% | |
| 13.7757% | |
| 11.6417% | |
| 25.7007% | |
| 38.6225% | |
| 32.8989% | |
| 53.4388% | |
| 46.8991% | |
| 34.9537% | |
| 32.1106% | |
| 20.009% | |
| 48.1526% | |
| 41.7816% | |
| 46.2668% | |
| 37.0298% | |
| 47.9455% | |
| 87.0733% | |
| 220.3929% | |
| 298.0563% | |
| 163.0508% | |
| 96.2861% | |
| -9.835% | |
| -3.0528% | |
| -6.9847% | |
| 8.7583% | |
| 38.027% | |
| -9.7245% | |
| 28.8894% | |
| 37.8447% | |
| 74.6422% | |
| 79.169% | |
| 47.7374% | |
| 32.2899% | |
| -14.7134% | |
| 192.6449% | |
| 173.2422% | |
| 257.1257% | |
| 552.7834% | |
| 77.494% | |
| 34.9404% | |
| -3.5376% | |
| -35.1005% | |
| -2.9194% | |
| 11.9597% | |
| 19.3104% | |
| -64.9693% | |
| -52.9728% | |
| -47.3233% | |
| -77.0468% | |
| 114.1714% | |
| 119.4214% | |
| 171.4786% | |
| 531.0982% | |
| 539.2028% | |
| 154.575% | |
| 177.0496% | |
| 157.1972% | |
| -1.6363% | |
| 17.1897% | |
| -4.7766% | |
| -46.6145% | |
| -69.6666% | |
| -66.0642% |